ArticlePharmacology research & perspectives2022

Pharmacological hypothesis: A recombinant probiotic for taming bacterial β-glucuronidase in drug-induced enteropathy.

Manon Jardou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.